# LISDEXAMFETAMINE DIMESYLATE
> **ANDA217442** · Abbreviated New Drug Application (Generic) · Sponsor: ASCENT PHARMS INC · Approved 2023-08-25
## Drug
- **FDA Application Number:** ANDA217442
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LISDEXAMFETAMINE DIMESYLATE
- **Generic name:** LISDEXAMFETAMINE DIMESYLATE
- **Active ingredients:** LISDEXAMFETAMINE DIMESYLATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ASCENT PHARMS INC
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2023-08-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217442)
---
*MORVS · CC0 1.0*